Broken String Biosciences launches BaseMap ABE to enable genome-wide off-target characterization in base editing therapeutic development

Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today announced the launch of BaseMap™ ABE. Built on the Company’s INDUCE-seq® technology, BaseMap ABE extends the platform’s capabilities to support adenine base editing (ABE) applications.